Chris Sale Was a One-Man Rotation — and That's the Braves' Real Winter Problem

The 2026 Braves won the NL East, finished 94-68, and were gone by the second week of October, eliminated by the Dodgers in four games. That's a good season with an ugly ending, and the autopsy doesn't require much imagination: Atlanta ran out of starting pitching.

Except for one man.

Chris Sale, at this stage of his career, just authored the best year of anyone in the rotation by a country mile: 27 starts, a 2.16 ERA across 162.2 innings, 200 strikeouts against 31 walks, a 0.98 WHIP, 5.5 WAR and an ERA+ of 196. His slider was borderline un-hittable — a .186 average against, a .247 slugging, a 38.2% whiff rate. His expected ERA (2.97) says it wasn't a fluke pile of luck, either.

And he went 14-9. That record tells you as much about the team around him as anything on his Baseball-Reference page.

Twenty-Nine Pitchers, One Certainty

The Braves used 29 pitchers in 2026. That's not a rotation; that's a triage unit with a roster spot. The 60-day injured list right now reads like a projected Opening Day staff: Spencer Schwellenbach, Spencer Strider, Hurston Waldrep, plus relievers Joe Jiménez and Joey Wentz. Schwellenbach's elbow fracture was the season's cruelest twist — the reporting this week that details of the injury cast a genuine cloud over his 2027 availability is the single most consequential item on Atlanta's winter agenda, because it removes the obvious internal answer.

Grant Holmes (3.44 ERA in 29 starts, 151.2 innings) was the last man standing from the original rotation. Bryce Elder gave them 26 starts and a 4.11 ERA. Reynaldo López's 4.54 ERA in a swing role didn't solve anything. When Sale wasn't on the mound in October, the Braves were improvising, and against a Dodgers lineup that's not a survivable plan.

What Anthopoulos Actually Said

Alex Anthopoulos met the media at season's end and, per usual, revealed very little in the way of specifics — while conceding the Braves would be "open-minded" about how to improve. More telling is what's been reported around the edges: shortstop and starting pitcher have been framed as the priority spots, and the framing of Atlanta's 2027 rotation as "messy" isn't a hot take so much as a summary. He did toss in intriguing comments about Didier Fuentes, which is what you say when the depth chart is a Wishlist.

The shortstop need is easy to explain. Ha-Seong Kim hit .116 with a .359 OPS across 51 games after being claimed late in the year — a black hole in a lineup that otherwise had real thump (Matt Olson's 41 homers, Michael Harris II at .294 with 26, Drake Baldwin's .817 OPS behind the plate). Ozzie Albies' .685 OPS is a separate headache. Ronald Acuña Jr. played 107 games and posted a .796 OPS — useful, not yet vintage.

The Cheapest Fix Might Be Re-Signing the Guy They Just Had

Tyler Mahle, a pending free agent acquired at the deadline, made 27 starts with a 3.99 ERA and 149 innings — mediocre on paper, invaluable in practice, and reportedly open to returning. In a market where frontline starters cost a fortune in years and prospects, bringing Mahle back is the path of least resistance for a club that needs volume more than it needs another ace.

Because the ace is already there. Sale, at 2.16, is a legitimate Cy Young-caliber anchor for 2027. But one starter doesn't cover 1,450 innings, and the Braves just learned that lesson the hard way — a 94-win season that ended the moment the calendar flipped to October and the rotation behind him became a question with no good answer.

Until Schwellenbach's elbow and Strider's arm have real timelines, that's the story in Atlanta: the best pitcher on the team can't pitch every day, and right now nobody else is promised anything.